The study compared the European Union system for biosimilar introduction to that of the United States and evaluated the savings that would have arisen from the presence of multiple biosimilars of Humira.
NCPA, NACDS, and WSPA are hailing a move by the Department of Justice that could signal victory in their case against low Medicaid reimbursements for pharmacies.
Desipramine hydrochloride tablets had a market value of roughly $7 million, while erlotinib tablets had a market value of $37 million, for the 12 months ended March 2021, according to IQVIA.
Bayer’s Kerendia is the first and only nonsteroidal mineralocorticoid receptor antagonist approved for adults with chronic kidney disease associated with Type 2 diabetes.